Description

The generation of human or humanized antibodies to human antigens is of particular interest for the treatment of a variety of diseases. Creative Biolabs is pleased to present world-leading De Novo Human/Humanized Antibody Sequencing service. Scientists from Creative Biolabs has developed De Novo antibody sequencing technology-- Database Assisted Shotgun Sequencing (DASS), which is an analytical method that derives an antibody’s amino acid sequence from its tandem mass spectrum (MS/MS) without the assistance of a sequence database. It is in contrast to another popular peptide identification approach– “database search”, which searches in a given database to find the target peptide.